Why Phase II/III Service Providers Lose Bids
Source: ISR Reports
In Q2, 2020, ISR asked 146 respondents involved in outsourcing Phase II/III services what is the main reason a CRO may lose bids for Phase II/III work. High cost topped the list, capturing 37% of respondents’ votes. Followed by Lack of therapeutic experience (19%) and Lack of understanding of the trial outcomes (12%). For more information, follow the link to the Phase II/III Study Trends and Market Outlook (2020-2024) report preview.
VIEW THE INFOGRAPHIC! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader